CJC-1295

CJC-1295 (No DAC), also referred to as modified GRF (1-29), is a synthetic 30-amino-acid peptide analog of the N-terminal fragment of endogenous growth-hormone-releasing factor (GRF/GHRH). The "No DAC" designation indicates that this construct omits the Drug Affinity Complex modification, distinguishing it from its longer-acting counterpart. It belongs to the growth-hormone secretagogue class of research peptides and is characterized in the laboratory by its receptor-recognition sequence and stabilizing amino-acid substitutions. Each vial contains 5mg of lyophilized powder verified to >=99% purity by HPLC, supplied strictly for in-vitro and non-clinical laboratory study.

Within companion-animal research programs, CJC-1295 (No DAC) is studied primarily as a reference compound for GHRH-receptor signaling and growth-hormone secretagogue pathways in canine and feline model systems. Investigators use it as a well-defined tool molecule when characterizing receptor-binding behavior, downstream signal-transduction cascades, and comparative peptide-stability profiles under controlled bench conditions. Its consistent, high-purity presentation makes it of research interest for assay development and method validation where a reproducible secretagogue-class standard is required.

The compound is additionally investigated for its role in metabolic and recovery-oriented research models relevant to dogs and cats, where laboratory teams examine secretagogue signaling in the context of energy-balance and tissue-recovery pathway studies. All such work is conducted in vitro or within established non-clinical study frameworks. CJC-1295 (No DAC) is offered exclusively as a Research Use Only material and is not intended for human or veterinary use, diagnosis, treatment, or any in-vivo administration.